Alice Han

A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline

Nicholas Van Hise, Russell M. Petrak, Nathan C. Skorodin et al. · Infectious Diseases and Therapy · 2020 · 29 citations · Full text

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2

Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise et al. · Clinical and Translational Science · 2020 · 22 citations · Full text

Il-6 Receptor Antagonist, Acute Care, Immunology +13

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2

Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise et al. · 2020 · 19 citations · Full text

Immunology, Early Dosing, Antiviral Drug +17

Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2

Russell M. Petrak, Nicholas W. Van Hise, Nathan C. Skorodin et al. · Critical Care Explorations · 2021 · 15 citations · Full text

Persistent SARS-CoV-2 infectivity greater than 50 days in a case series of allogeneic peripheral blood stem cell transplant recipients

Alice Han, Tulio E. Rodriguez, Eric T. Beck et al. · Current Problems in Cancer Case Reports · 2021 · 12 citations · Full text

Viral Diagnostics, Immunology, Case Series +16